HARP - Harpoon Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5369.82M
Enterprise Value 3263.63M
Trailing P/E N/A
Forward P/E 1-8.34
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)80.33
Price/Book (mrq)3.45
Enterprise Value/Revenue 357.26
Enterprise Value/EBITDA 6-5.01

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 37.43%
S&P500 52-Week Change 321.38%
52 Week High 321.47
52 Week Low 39.06
50-Day Moving Average 314.67
200-Day Moving Average 314.63

Share Statistics

Avg Vol (3 month) 3151.16k
Avg Vol (10 day) 3127.53k
Shares Outstanding 524.64M
Float 7.54M
% Held by Insiders 129.23%
% Held by Institutions 161.24%
Shares Short (Jan 30, 2020) 4351.03k
Short Ratio (Jan 30, 2020) 42.46
Short % of Float (Jan 30, 2020) 44.89%
Short % of Shares Outstanding (Jan 30, 2020) 41.42%
Shares Short (prior month Dec 30, 2019) 4249.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,157.10%

Management Effectiveness

Return on Assets (ttm)-38.12%
Return on Equity (ttm)-82.93%

Income Statement

Revenue (ttm)4.6M
Revenue Per Share (ttm)0.28
Quarterly Revenue Growth (yoy)33.30%
Gross Profit (ttm)-21.62M
EBITDA -52.68M
Net Income Avi to Common (ttm)-51.04M
Diluted EPS (ttm)-3.15
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)121.23M
Total Cash Per Share (mrq)4.92
Total Debt (mrq)15.04M
Total Debt/Equity (mrq)14.02
Current Ratio (mrq)7.37
Book Value Per Share (mrq)4.36

Cash Flow Statement

Operating Cash Flow (ttm)-43.05M
Levered Free Cash Flow (ttm)-25.83M